The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ₹233 crore compared to ₹210 crore in the same quarter last year.
Ajanta Pharma Q3 Results: Net profit rises 11% to ₹233 crore, but margin declines 1%
Share it
